HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
CNNM2
cyclin and CBS domain divalent metal cation transport mediator 2
Chromosome 10 Β· 10q24.32
NCBI Gene: 54805Ensembl: ENSG00000148842.19HGNC: HGNC:103UniProt: Q9H8M5
63PubMed Papers
22Diseases
0Drugs
38Pathogenic Variants
FUNCTIONAL ROLE
Highly ConstrainedTransporter
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
basolateral plasma membranemagnesium ion homeostasisplasma membranemagnesium ion transmembrane transporter activityfamilial primary hypomagnesemia with normocalciuria and normocalcemiahypomagnesemia, seizures, and intellectual disabilityAutosomal dominant primary hypomagnesemia with hypocalciuriahypertension
✦AI Summary

CNNM2 encodes a divalent metal cation transporter mediating magnesium (Mg2+) homeostasis with substrate preference Mg2+ > Co2+ > Mn2+ > Sr2+ > Ba2+ > Cu2+ > Fe2+ 1. In the kidney's distal convoluted tubule, CNNM2 facilitates basolateral Mg2+ extrusion in a sodium-dependent manner, contributing to fine-tuning of systemic Mg2+ reabsorption 1. Mg2+ is essential for over 600 enzymatic reactions including energy metabolism and protein synthesis 2. CNNM2 mutations cause autosomal recessive hypomagnesemia with neurological manifestations 2. Beyond ion transport, CNNM2 emerges as a schizophrenia risk gene identified through genome-wide association studies 34. Reduced CNNM2 expression in prefrontal cortex impairs sensorimotor gating and cognition while altering dendritic spine morphogenesis in mice, supporting its neurobiological relevance 5. DNA methylation of CNNM2 is causally associated with schizophrenia in both brain and blood 6. CNNM2 variants also associate with hypertension risk in Chinese populations 7 and intracranial aneurysm susceptibility, particularly aneurysm rupture 8. These findings establish CNNM2 as functionally important for both metabolic Mg2+ homeostasis and neuropsychiatric disease pathogenesis.

Sources cited
1
CNNM2 facilitates basolateral Mg2+ extrusion in kidney distal convoluted tubule via Na+-dependent mechanism
PMID: 38871680
2
CNNM2 mutations cause hereditary hypomagnesemia and are involved in Mg2+ homeostasis regulation
PMID: 25540137
3
CNNM2 identified as promising schizophrenia candidate gene with altered brain phenotypes in zebrafish model
PMID: 30929901
4
CNNM2 identified as potential causal gene for schizophrenia through cross-ancestry GWAS and gene-level analyses
PMID: 39753749
5
Decreased CNNM2 expression in prefrontal cortex impairs sensorimotor gating, cognition, and dendritic spine morphogenesis
PMID: 37715107
6
DNA methylation at CNNM2 locus causally associated with schizophrenia in both brain and blood
PMID: 40157589
7
CNNM2 gene polymorphisms associated with reduced hypertension risk in Chinese Han population
PMID: 30180964
8
CNNM2 protein abundance associated with intracranial aneurysm risk and rupture through proteome and expression analyses
PMID: 39084678
Disease Associationsβ“˜22
familial primary hypomagnesemia with normocalciuria and normocalcemiaOpen Targets
0.74Strong
hypomagnesemia, seizures, and intellectual disabilityOpen Targets
0.55Moderate
Autosomal dominant primary hypomagnesemia with hypocalciuriaOpen Targets
0.55Moderate
hypertensionOpen Targets
0.46Moderate
Autosomal recessive spastic paraplegia type 48Open Targets
0.45Moderate
hereditary spastic paraplegia 45Open Targets
0.45Moderate
Abnormality of the skeletal systemOpen Targets
0.44Moderate
HypomagnesemiaOpen Targets
0.34Weak
major depressive disorderOpen Targets
0.32Weak
atrial fibrillationOpen Targets
0.31Weak
schizophreniaOpen Targets
0.31Weak
coronary artery diseaseOpen Targets
0.30Weak
cardiovascular diseaseOpen Targets
0.29Weak
uterine fibroidOpen Targets
0.27Weak
diabetes mellitusOpen Targets
0.27Weak
type 2 diabetes mellitusOpen Targets
0.26Weak
Moyamoya diseaseOpen Targets
0.26Weak
sign or symptomOpen Targets
0.25Weak
migraine disorderOpen Targets
0.25Weak
attention deficit hyperactivity disorderOpen Targets
0.25Weak
Hypomagnesemia 6UniProt
Hypomagnesemia, seizures, and impaired intellectual development 1UniProt
Pathogenic Variants38
NM_017649.5(CNNM2):c.806C>G (p.Ser269Trp)Pathogenic
Hypomagnesemia, seizures, and intellectual disability 1
β˜…β˜…β˜†β˜†2025β†’ Residue 269
NM_017649.5(CNNM2):c.1804C>T (p.Arg602Ter)Likely pathogenic
See cases|Renal hypomagnesemia 6;Hypomagnesemia, seizures, and intellectual disability 1
β˜…β˜…β˜†β˜†2024β†’ Residue 602
NM_017649.5(CNNM2):c.318C>A (p.Tyr106Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 106
NM_017649.5(CNNM2):c.980A>G (p.Asn327Ser)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 327
NM_017649.5(CNNM2):c.52_55dup (p.Ala19fs)Likely pathogenic
Hypomagnesemia, seizures, and intellectual disability 1;Renal hypomagnesemia 6
β˜…β˜†β˜†β˜†2025β†’ Residue 19
NM_017649.5(CNNM2):c.1207C>T (p.Gln403Ter)Likely pathogenic
Hypomagnesemia, seizures, and intellectual disability 1
β˜…β˜†β˜†β˜†2025β†’ Residue 403
NM_017649.5(CNNM2):c.2389C>T (p.Arg797Ter)Likely pathogenic
Hypomagnesemia, seizures, and intellectual disability 1|not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 797
NM_017649.5(CNNM2):c.1300ATC[1] (p.Ile435del)Likely pathogenic
Hypomagnesemia, seizures, and intellectual disability 1
β˜…β˜†β˜†β˜†2024β†’ Residue 435
NM_017649.5(CNNM2):c.1936del (p.Glu646fs)Pathogenic
CNNM2-Related Disorders
β˜…β˜†β˜†β˜†2024β†’ Residue 646
NM_017649.5(CNNM2):c.1069G>A (p.Glu357Lys)Pathogenic
Hypomagnesemia, seizures, and intellectual disability 1|not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 357
NM_017649.5(CNNM2):c.1862C>A (p.Ser621Ter)Likely pathogenic
Hypomagnesemia, seizures, and intellectual disability 1;Renal hypomagnesemia 6
β˜…β˜†β˜†β˜†2024β†’ Residue 621
NM_017649.5(CNNM2):c.274del (p.Ala92fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 92
NM_017649.5(CNNM2):c.1601del (p.Met534fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 534
NM_017649.5(CNNM2):c.12T>A (p.Cys4Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 4
NM_017649.5(CNNM2):c.1764C>G (p.Tyr588Ter)Likely pathogenic
Hypomagnesemia, seizures, and intellectual disability 1;Renal hypomagnesemia 6
β˜…β˜†β˜†β˜†2024β†’ Residue 588
NM_017649.5(CNNM2):c.1067G>A (p.Gly356Glu)Likely pathogenic
Hypomagnesemia, seizures, and intellectual disability 1
β˜…β˜†β˜†β˜†2023β†’ Residue 356
NM_017649.5(CNNM2):c.970G>C (p.Val324Leu)Pathogenic
Hypomagnesemia, seizures, and intellectual disability 1
β˜…β˜†β˜†β˜†2023β†’ Residue 324
NM_017649.5(CNNM2):c.1291G>A (p.Glu431Lys)Pathogenic
Renal hypomagnesemia 6
β˜…β˜†β˜†β˜†2023β†’ Residue 431
NM_017649.5(CNNM2):c.2384C>A (p.Ser795Ter)Pathogenic
Renal hypomagnesemia 6
β˜…β˜†β˜†β˜†2023β†’ Residue 795
NM_017649.5(CNNM2):c.274G>C (p.Ala92Pro)Pathogenic
Hypomagnesemia, seizures, and intellectual disability 1
β˜…β˜†β˜†β˜†2023β†’ Residue 92
View on ClinVar β†—
Related Genes
PTP4A1Protein interaction97%GMPSProtein interaction93%AS3MTProtein interaction82%SLC41A1Protein interaction80%PTP4A2Protein interaction80%CBSProtein interaction79%
Tissue Expression6 tissues
Bone Marrow
100%
Brain
88%
Ovary
53%
Liver
45%
Lung
36%
Heart
34%
Gene Interaction Network
Click a node to explore
CNNM2PTP4A1GMPSAS3MTSLC41A1PTP4A2CBS
PROTEIN STRUCTURE
Preparing viewer…
PDB4IYS Β· 1.80 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.31Highly Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.19 [0.12–0.31]
RankingsWhere CNNM2 stands among ~20K protein-coding genes
  • #7,348of 20,598
    Most Researched63
  • #1,596of 5,498
    Most Pathogenic Variants38
  • #1,236of 17,882
    Most Constrained (LOEUF)0.31 Β· top 10%
Genes detectedCNNM2
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Magnesium in man: implications for health and disease.
PMID: 25540137
Physiol Rev Β· 2015
1.00
2
Magnesium biology.
PMID: 38871680
Nephrol Dial Transplant Β· 2024
0.90
3
Phenotypic Landscape of Schizophrenia-Associated Genes Defines Candidates and Their Shared Functions.
PMID: 30929901
Cell Β· 2019
0.80
4
Identifying novel risk genes in intracranial aneurysm by integrating human proteomes and genetics.
PMID: 39084678
Brain Β· 2024
0.70
5
Gene-level analysis reveals the genetic aetiology and therapeutic targets of schizophrenia.
PMID: 39753749
Nat Hum Behav Β· 2025
0.60